In humanized lung cancer model, RIG-I activated by MAPK/IRF1 triggered an interferon and a pro-apoptotic response, resulting in the reduction of exhausted CD8+ T cells and tumor shrinkage [70]. The gene discussed is RIGI; the disease is neoplasm.